Toward the Development of Biomimetic Polymers by Protein Immobilization: PEGylation of Insulin as a Model Reaction

Tissue Engineering

Volumn 10, Issue 3-4, 2004, Pages 441-453

  Tessmar, Jörg ^a   Kellner, Karin ^a   Schulz, Michaela B ^a   Blunk, Torsten ^a   Göpferich, Achim ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMIMETIC MATERIAL; INSULIN; MACROGOL; POLYMER;

CELL ADHESION; CHEMICAL STRUCTURE; CONFERENCE PAPER; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE; GEL PERMEATION CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TISSUE ENGINEERING;

ANIMALS; BINDING SITES; BIOMIMETIC MATERIALS; CARTILAGE; CATTLE; CELL CULTURE TECHNIQUES; CHONDROCYTES; HUMANS; INSULIN; POLYETHYLENE GLYCOLS;

EID: 2342529068     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/107632704323061807     Document Type: Conference Paper

References (25)

1. Langer, R., Cima, L.G., Tamada, J.A., and Wintermantel, E. Future directions in biomaterials. Biomaterials 11, 738, 1990.
2. Hubbell, J.A. Bioactive biomaterials. Curr. Opin. Biotechnol. 10, 123, 1999.
3. Hubbell, J.A. Biomaterials in tissue engineering. Biotechnology 13, 565, 1995.
4. Babensee, J.E., McIntire, L.V., and Mikos, A.G. Growth factor delivery for tissue engineering. Pharm. Res. 17, 497, 2000.
5. Nikolovski, J., and Mooney, D.J. Smooth muscle cell adhesion to tissue engineering scaffolds. Biomaterials 21, 2025, 2000.
6. Quirk, R.A., Chan, W.C., Davies, M.C., Tendler, S.J.B., and Shakesheff, K.M. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials 22, 865, 2001.
7. Mann, B.K., Schmedlen, R.H., and West, J.L. Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22, 439, 2001.
8. Whitaker, M.J., Quirk, R.A., Howdle, S.M., and Shakesheff, K.M. Growth factor release from tissue engineering scaffolds. J. Pharm. Pharmacol. 53, 1427, 2001.
9. Kuhl, P.R., and Griffith-Cima, L.G. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase [published erratum appears in Nat. Med. 1997;3:93]. Nat. Med. 2, 1022, 1996.
10. Kuhl, P.R., and Griffith-Cima, L.G. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase [published erratum appears in Nat. Med. 1997;3:93]. Nat. Med. 2, 1022, 1996.
11. Tessmar, J.K., Mikos, A.G., and Goepferich, A. Amine-reactive biodegradable diblock copolymers. Biomacromolecules 3, 194, 2002.
12. Tessmar, J.K., Mikos, A.G., and Goepferich, A. The use of poly(ethylene glycol)-block-poly(lactic acid) derived copolymers for the rapid creation of biomimetic surfaces. Biomaterials 24, 4475, 2003.
13. Klee, D., and Hoecker, H. Polymers for biomedical applications: Improvement of the interface compatibility. Adv. Polym. Sci. 149, 1, 1999.
14. Bailon, P., and Berthold, W. Polyethylene glycol-conjugated pharmaceutical proteins. Pharm. Sci. Technol. Today 1, 352, 1998.
15. Inada, Y., Furukawa, M., Sasaki, H., Kodera, Y., Hiroto, M., Nishimura, H., and Matsushima, A. Biomedical and biotechnological applications of PEG- and PM-modified proteins. Trends Biotechnol. 13, 86, 1995.
16. Nucci, M.L., Shorr, R., and Abuchowski, A. The therapeutic value of polyethylene glycol-modified proteins. Adv. Drug Deliv. Rev. 6, 133, 1991.
17. Abuchowski, A., Kazo, G.M., Verhoest-CR, J., Van Es, T., Kafkewitz, D., Nucci, M.L., Viau, A.T., and Davis, F.F. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem. Biophys. 7, 175, 1984.
18. Liu, F., Song, S.C., Mix, D., Baudys, M., and Kim, S.W. Glucose-induced release of glycosylpoly(ethylene glycol) insulin bound to a soluble conjugate of concanavalin A. Bioconjug. Chem. 8, 664, 1997.
19. Kellner, K., Schulz, M.B., Göpferich, A., and Blunk, T. Insulin in tissue engineering of cartilage: A potential model system for growth factor application. J. Drug Target. 9, 439, 2001.
20. Kellner, K., Tessmar, J., Milz, S., Angele, P., Schulz, M.B., Nerlick, M., Schulz, M.B., Blunk, T., and Göpferich, A. PEGylation does not impair insulin efficacy in 3-D cartilage culture: An investigation toward biomimetic polymers. Tissue Eng. 10, 429, 2004.
21. Harris, J.M. Laboratory synthesis of polyethylene glycol derivatives. J. Macromol. Sci. C Rev. Macromol. Chem. Phys. 25, 325, 1985.
22. Yokoyama, M., Okano, T., Sakurai, Y., Kikuchi, A., Ohsako, N., Nagasaki, Y., and Kataoka, K. Synthesis of poly(ethylene oxide) with heterobifunctional reactive groups at its terminals by an anionic initiator. Bioconjug. Chem. 3, 275, 1992.
23. Anderson, G.W., Zimmermann, J.E., and Callahan, F.M. The use of esters of N-hydroxysuccinimide in peptide synthesis. J. Am. Chem. Soc. 86, 1839, 1964.
24. Hinds, K.D., and Kim, S.W. Effects of PEG conjugation on insulin properties. Adv. Drug Deliv. Rev. 54, 505, 2002.
25. Brange, J., and Langkjaer, L. Insulin Structure and Stability. In: Wang, Y.J., and Pearlman, R., eds. Stability and Characterization of Protein and Peptide Drugs: Case Histories. New York: Plenum Press, 1993, pp. 315-350.